Les Sulewski
Stock Analyst at Truist Financial
(3.91)
# 1,870
Out of 4,996 analysts
185
Total ratings
50.8%
Success rate
8%
Average return
Main Sectors:
Stocks Rated by Les Sulewski
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CRMD CorMedix | Reiterated: Buy | n/a | $7.69 | - | 23 | May 15, 2026 | |
| COLL Collegium Pharmaceutical | Reiterated: Buy | n/a | $22.45 | - | 20 | May 14, 2026 | |
| ANIP ANI Pharmaceuticals | Reiterated: Hold | n/a | $74.43 | - | 25 | May 11, 2026 | |
| VTRS Viatris | Reiterated: Buy | $20 | $17.12 | +16.82% | 8 | May 8, 2026 | |
| VNDA Vanda Pharmaceuticals | Reiterated: Buy | $18 | $5.04 | +257.14% | 4 | May 7, 2026 | |
| PCRX Pacira BioSciences | Reiterated: Buy | n/a | $24.63 | - | 24 | May 1, 2026 | |
| TSX: BHC Bausch Health Companies Inc. | Reiterated: Hold | n/a | $8.04 | - | 18 | May 1, 2026 | |
| TEVA Teva Pharmaceutical Industries | Rated: Buy | $42 → $45 | $39.01 | +15.36% | 11 | Apr 30, 2026 | |
| AMRX Amneal Pharmaceuticals | Reiterated: Buy | n/a | $19.33 | - | 21 | Apr 23, 2026 | |
| BTMD biote | Reiterated: Buy | $5 → $4 | $1.30 | +207.69% | 19 | Apr 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | €22.00 | €23.20 | n/a | 1 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $85.86 | n/a | 1 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $23.93 → $19.70 | $18.13 | n/a | 5 | Jul 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $3.01 | n/a | 5 | Jul 9, 2024 |
CorMedix
May 15, 2026
Reiterated: Buy
Price Target: n/a
Current: $7.69
Upside: -
Collegium Pharmaceutical
May 14, 2026
Reiterated: Buy
Price Target: n/a
Current: $22.45
Upside: -
ANI Pharmaceuticals
May 11, 2026
Reiterated: Hold
Price Target: n/a
Current: $74.43
Upside: -
Viatris
May 8, 2026
Reiterated: Buy
Price Target: $20
Current: $17.12
Upside: +16.82%
Vanda Pharmaceuticals
May 7, 2026
Reiterated: Buy
Price Target: $18
Current: $5.04
Upside: +257.14%
Pacira BioSciences
May 1, 2026
Reiterated: Buy
Price Target: n/a
Current: $24.63
Upside: -
Bausch Health Companies Inc.
May 1, 2026
Reiterated: Hold
Price Target: n/a
Current: $8.04
Upside: -
Teva Pharmaceutical Industries
Apr 30, 2026
Rated: Buy
Price Target: $42 → $45
Current: $39.01
Upside: +15.36%
Amneal Pharmaceuticals
Apr 23, 2026
Reiterated: Buy
Price Target: n/a
Current: $19.33
Upside: -
biote
Apr 16, 2026
Reiterated: Buy
Price Target: $5 → $4
Current: $1.30
Upside: +207.69%
May 27, 2025
Initiated Coverage: Buy
Price Target: €22.00
Current: €23.20
Upside: n/a
Aug 8, 2024
Reiterated: Buy
Price Target: n/a
Current: $85.86
Upside: n/a
Jul 26, 2024
Reiterated: Buy
Price Target: $23.93 → $19.70
Current: $18.13
Upside: n/a
Jul 9, 2024
Rated: Hold
Price Target: n/a
Current: $3.01
Upside: n/a